We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
Cap. Flow
-$209M
Cap. Flow %
-30.05%
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257

Top Buys

Rank Stock Value
1
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$2.36M
2
COLL icon
Collegium Pharmaceutical
COLL
+$2.32M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$2.29M
4
HSII
Heidrick & Struggles
HSII
+$2.25M
5
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
+$2.17M

Top Sells

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$5.99M
2
CMC icon
Commercial Metals
CMC
+$5.95M
3
BHE icon
Benchmark Electronics
BHE
+$5.84M
4
UPBD icon
Upbound Group
UPBD
+$5.71M
5
RAIL icon
FreightCar America
RAIL
+$5.51M

Sector Composition

Rank Sector Weight
1 Healthcare 18.04%
2 Industrials 15.17%
3 Technology 12.86%
4 Consumer Discretionary 12.11%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDTI
276
DELISTED
Integrated Device Technology I
IDTI
$933K 0.13%
+45,658
New +$960K
ZVO
277
DELISTED
Zovio Inc. Common Stock
ZVO
$929K 0.13%
+92,156
New +$700K
AMPH icon
278
Amphastar Pharmaceuticals
AMPH
$840M
$928K 0.13%
77,360
-183,066
-70% -$2.16M
CNXN icon
279
PC Connection
CNXN
$2.04B
$927K 0.13%
35,911
-29,796
-45% -$680K
SXI icon
280
Standex International
SXI
$3.66B
$924K 0.13%
11,877
-6,716
-36% -$488K
BLT
281
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
$921K 0.13%
92,290
+34,478
+60% +$331K
LPNT
282
DELISTED
LifePoint Health, Inc.
LPNT
$919K 0.13%
+13,275
New +$886K
GDOT icon
283
Green Dot
GDOT
$753M
$914K 0.13%
+39,800
New +$773K
AMAG
284
DELISTED
AMAG Pharmaceuticals
AMAG
$910K 0.13%
+38,870
New +$923K
NXGN
285
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$908K 0.13%
+59,605
New +$904K
MNTA
286
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$891K 0.13%
96,386
-81,775
-46% -$880K
ARLZ
287
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$891K 0.13%
+250,969
New +$1.29M
ALR
288
DELISTED
AlerisLife Inc
ALR
$884K 0.13%
38,612
-21,414
-36% -$526K
PRSU
289
Pursuit Attractions and Hospitality Inc
PRSU
$1.44B
$880K 0.13%
+30,166
New +$849K
EXPR
290
DELISTED
Express, Inc.
EXPR
$869K 0.13%
2,029
+1,236
+156% +$444K
CYTK icon
291
Cytokinetics
CYTK
$11B
$860K 0.12%
+122,027
New +$891K
KODK icon
292
Kodak
KODK
$787M
$860K 0.12%
+79,250
New +$776K
LNW
293
DELISTED
Light & Wonder
LNW
$857K 0.12%
+90,830
New +$678K
CKP
294
DELISTED
CHECKPOINT SYSTEMS INC
CKP
$857K 0.12%
84,705
-39,014
-32% -$298K
KKD
295
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$854K 0.12%
+54,801
New +$795K
NUTR
296
DELISTED
Nutraceutical International Co
NUTR
$852K 0.12%
35,004
-41,752
-54% -$1.01M
TEX icon
297
Terex
TEX
$7.78B
$849K 0.12%
34,131
-9,268
-21% -$194K
MRC
298
DELISTED
MRC Global
MRC
$847K 0.12%
64,433
-316,174
-83% -$3.64M
SANM icon
299
Sanmina
SANM
$10.9B
$847K 0.12%
+36,235
New +$728K
GTLS
300
DELISTED
Chart Industries
GTLS
$845K 0.12%
+38,903
New +$695K
10 11
12
13 14

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q1 2016 Portfolio in Review

As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.

  • TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
  • TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
  • TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
  • TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
  • TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
  • TFS Capital opened 502 new positions and closed 257 in Q1 2016.
  • TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.